
Corporate Event Notice
Delisting of shares As of 28/09/2018, ordinary shares (ISIN PTCPN0AE0002) issued by CIPAN-IND.PRODUTOS ANTIBIOTIC. will be deliste
Cipan is a company dedicated to the research, development and production of Active Pharmaceutical Ingredients and Advanced intermediates. Founded by Sebastiao Alves in 1960, it has been involved mainly in the development and production of different types of antibiotics by both fermentation and chemical synthesis.
The factory was inspected by the FDA in 1965 for the first time and has since been favorably inspected by the FDA and other regulatory authorities
With almost six decades of experience in the development and production of Tetracyclines, Cipan has become the world leader in the production of this class of Antibiotics and other Active Ingredients.
Cipan is also a Contract Development and Manufacturing organization and is a company of the ![]()

Delisting of shares As of 28/09/2018, ordinary shares (ISIN PTCPN0AE0002) issued by CIPAN-IND.PRODUTOS ANTIBIOTIC. will be deliste

Together with Suanfarma, CIPAN will be present at DCAT Week, March 20-23, 2017. We will be glad to meet you at suite no.1903 at th

Suanfarma has successfully completed the acquisition of CIPAN (Companhia Industrial Productora de Antibioticos), a prestigious int

Cipan is increasing its production of Minocycline HCl in 2017. With a production capacity of 30 Ton/year, Cipan has produced small